Cogent Biosciences (COGT) Change in Cash: 2017-2024
Historic Change in Cash for Cogent Biosciences (COGT) over the last 8 years, with Dec 2024 value amounting to $44.9 million.
- Cogent Biosciences' Change in Cash fell 85.11% to $16.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$22.5 million, marking a year-over-year decrease of 110.99%. This contributed to the annual value of $44.9 million for FY2024, which is 151.11% up from last year.
- According to the latest figures from FY2024, Cogent Biosciences' Change in Cash is $44.9 million, which was up 151.11% from -$87.9 million recorded in FY2023.
- In the past 5 years, Cogent Biosciences' Change in Cash ranged from a high of $204.8 million in FY2020 and a low of -$87.9 million during FY2023.
- In the last 3 years, Cogent Biosciences' Change in Cash had a median value of -$79.8 million in 2022 and averaged -$40.9 million.
- Per our database at Business Quant, Cogent Biosciences' Change in Cash spiked by 1,222.19% in 2020 and then plummeted by 254.56% in 2022.
- Over the past 5 years, Cogent Biosciences' Change in Cash (Yearly) stood at $204.8 million in 2020, then crashed by 110.99% to -$22.5 million in 2021, then tumbled by 254.56% to -$79.8 million in 2022, then decreased by 10.17% to -$87.9 million in 2023, then soared by 151.11% to $44.9 million in 2024.